View the AZIMAX-250 registration information details.
Back to drug list
ItemsDrug Registration information
ID287
No287
Brand NameAZIMAX-250
IngredientsAZITHROMYCIN DIHYDRATE 262.05 MG EQ.TO AZITHROMYCIN 250 MG
Dosage FormFILM COATED TABLET
Primary PackagingBLISTERPACK
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 1 X 6'S, 5 X 6'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsBRONCHITIS, COMUNITY-ACQUIRED PNEUMONIA, SINUSITIS, PHARYNGITIS/TONSILITIS, OTITIS MEDIA, SKIN AND SOFT TISSUE INFECTION, UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionOBLONG, WHITE FILM-COATED TABLET, BEVEL-EDGED, SHALLOW CONVEX WITH BREAK-BAR ON ONE SIDE AND HOVID EMBOSSED ON THE OTHER SIDE
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4686/19
FDD Registration Date07/07/2025
Expiry Date06/07/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA